Changes Requiring Approval Clause Samples
The "Changes Requiring Approval" clause establishes that certain modifications to the agreement or project cannot be made unilaterally and must receive explicit consent from specified parties. Typically, this applies to significant changes such as alterations in scope, budget, timelines, or key deliverables, and often requires written approval from both parties before such changes take effect. This clause ensures that all stakeholders remain informed and in agreement about major adjustments, thereby preventing misunderstandings and disputes over unauthorized changes.
POPULAR SAMPLE Copied 1 times
Changes Requiring Approval. First, there are changes that we cannot make to debt securities without specific approval of all of the holders. The following is a list of those types of changes: • change the stated maturity of the principal of or interest on a debt security; • reduce any amounts due on a debt security; • reduce the amount of principal payable upon acceleration of the maturity of a security following a default; • adversely affect any right of repayment at the holder’s option; • change the place (except as otherwise described in the prospectus or prospectus supplement) or currency of payment on a debt security; • impair your right to sue for payment; • adversely affect any right to convert or exchange a debt security in accordance with its terms; • modify the subordination provisions in the indenture in a manner that is adverse to holders of the debt securities; • reduce the percentage of holders of debt securities whose consent is needed to modify or amend the indenture; • reduce the percentage of holders of debt securities whose consent is needed to waive compliance with certain provisions of the indenture or to waive certain defaults; • modify any other aspect of the provisions of the indenture dealing with supplemental indentures, modification and waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants; and • change any obligation we have to pay additional amounts.
Changes Requiring Approval. No material additions or supplementary sheets shall be made or added to the Plans and Specifications without the prior written approval of Inspecting Engineer acting on behalf of Lender, which approval shall not be unreasonably delayed or withheld. Borrower shall notify Inspecting Engineer in writing of all material changes and proposed changes in the Plans and Specifications. Such notification shall be delivered to Inspecting Engineer in sufficient time before the changes are scheduled to be incorporated in the work, so that they may be evaluated reasonably by Inspecting Engineer and Lender. Borrower shall obtain the prior written approval of Lender which approval shall not be unreasonably delayed or withheld, of any change in the Plans and Specifications that has an estimated increase or decrease in Project costs of Two Hundred Fifty Thousand United States Dollars (US$250,000) or more, with respect to any one change, or Five Hundred Thousand United States Dollars (US$500,000) or more, with respect to all changes in the aggregate or would result in a material change in the square footage of any space or in the structural composition of the Improvements.
Changes Requiring Approval. If a proposed Manufacturing Change requires the approval of a Governmental Authority in the Territory, then Purchaser shall use its reasonably diligent efforts to obtain such approval, and Amgen shall continue to provide Drug Product as prior to the Manufacturing Change as necessary to allow Purchaser to obtain the required approval; provided, however, that Amgen shall have the right to transition Purchaser to an alternate source of supply in accordance with Section 2.14 (Alternate Supply) at any time upon written notice given by Amgen to Purchaser. If Purchaser does not obtain approval of a proposed Manufacturing Change from the Governmental Authority in the Territory within the relevant time period, or becomes aware of a potential failure to timely receive such approval, Purchaser shall promptly notify Amgen thereof. In such event, Amgen shall have the right to transition Purchaser to an alternate source of supply in accordance with Section 2.14 (Alternate Supply) at any time upon written notice given by Amgen to Purchaser. Notwithstanding anything to the contrary in this Section 2.9 (Changes to Manufacturing), Amgen shall have the right to immediately make any change required to protect patient safety or as required by Law, and shall give Purchaser prompt written notice thereof.